SEC Adopts New Disclosure Rules Governing SPAC IPOs and De-Spac Transactions


The use of Special Purpose Acquisition Companies (“SPAC”)[1] for going public transactions (“IPOs”) has grown significantly over the last few years. So has litigation involving SPACs. On January 24, 2024, the Securities and Exchange Commission (“SEC”) adopted new rules to widen the disclosure requirements for SPAC IPOs and subsequent transactions between SPACs and target companies (“de-spac transaction”).[2 

These newly adopted rules are multi-faceted and apply to various forms of disclosures for the purpose of expanding information available for investors. For example, under the new Item 1603(a) of Regulation S-K, SPACs are required to disclose: (1) the SPAC’s sponsor’s experience, role(s), compensation and any existing or potential conflicts of interests; (2) the control person(s) of the SPAC sponsor; (3) tabular disclosure of the material terms of any lock-up agreements with the SPAC sponsor or its affiliates; and (4) the nature and amounts of all compensation earned by or paid to the sponsor, its affiliates and any promoters for all services rendered to the SPAC. 

These rules also address the SEC’s concerns regarding these transactions’ potential for dilution[3] by requiring that registration statements disclose the sources of dilution, potential future sources of dilution and other transactions that could affect dilution such as shareholder redemptions, warrants, convertible securities or private investment in public equity (“PIPE”) transactions. 

Critically, these new rules eliminate the Private Securities Litigation Reform Act’s (“PSLRA”) safe harbor protection for forward-looking statements made by SPACs. Prior to the rules' passage, SPACs were shielded from liability, like all publicly traded companies, for public disclosures that are considered to be forward-looking statements/projections[4] that were accompanied by meaningfully cautionary statements. The safe harbor does not protect forward looking statements made during IPOs or offerings by “blank-check companies” and by including SPACs within that definition, the SEC eliminates these protections for SPAC IPOs and de-spac transactions. 

Finally, these rules require the target company and its principal officers, in a registered de-SPAC transaction, to be a co-registrant (with the SPAC) and therefore an issuer on a registration statement. Consequently, it can be expected that target companies will face a greater threat of civil liability under Section 11 of the Securities Exchange Act of 1934.[5]
 
Overall, these newly adopted rules are more consistent with the PSLRA’s public registration requirements. Accordingly, traditionally undercapitalized companies should expect greater scrutiny when affecting public transactions.
 

_________________________________________________________

[1] As Harvard Business Review explains, SPACs are publicly traded corporations with a two-year life span formed for the sole purpose of allowing a privately held business, that lacks traditional capital requirements, to go public by way of a sponsoring company or individual. See Max H. Bazerman, SPACS: What You Need to Know, Feb. 15, 2024, https://hbr.org/2021/07/spacs-what-you-need-to-know.

[2] As netsuite.com explains, a de-spac transaction is one in which private companies go public by merging with a SPAC.

[3] Per Investopedia, dilution occurs when a company issues new shares that result in a decrease in existing stockholders' ownership percentage of that company. See Akhilesh Ganti, What Is Dilution in Trading Definition and Examples, Feb. 18, 2021, https://www.investopedia.com/terms/d/dilution.asp.

[4] The term “forward-looking statement” means— (A) a statement containing a projection of revenues, income (including income loss), earnings (including earnings loss) per share, capital expenditures, dividends, capital structure, or other financial items; (B) a statement of the plans and objectives of management for future operations, including plans or objectives relating to the products or services of the issuer; (C) a statement of future economic performance, including any such statement contained in a discussion and analysis of financial condition by the management or in the results of operations included pursuant to the rules and regulations of the Commission. 15 U.S.C. § 78u-5(i)(1).

[5]  Section 11 provides that issuers, underwriters, officers and directors of the issuer, and any other expert who helped prepare the registration statement (e.g. accountants, lawyers) are strictly liable for any misrepresentation or omission of material information, i.e. securities fraud, in their registration statement. 15 U.S.C. § 77k.

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Georgia and Pennsylvania.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

About Matthew A. Conrad

Matthew A. Conrad is an associate in the New York office of Faruqi & Faruqi. Mathew is focused on F&F's securities litigation practice.

Tags: faruqi & faruqi, faruqi law, faruqi blog, faruqilaw, Matthew Conrad, securities litigation, shareholder rights, stock fraud, SPAC, IPO Matthew A. Conrad Matthew A. Conrad
Associate at Faruqi & Faruqi, LLP

New York office
Tel: (212) 983-9330
Fax: (212) 983-9331
E-mail: mconrad@faruqilaw.com
Social: LinkedIn

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania